- Synonymsrac-13-Ethyl-17-hydroxy-18,19-dinor-17α-pregna-4,8(14)-dien-20-yn-3-one 18,19-Dinorpregna-4,8(14)-dien-20-yn-3-one, 13-ethyl-17-hydroxy-, (17α)-(±); (17α)-(±)-13-Ethyl-17-hydroxy-18,19-dinorpregna-4,8(14)-dien-20-yn-3-one; 8(14)-Dehydronorgestrel;
- Description
rac-13-Ethyl-17-hydroxy-18,19-dinor-17α-pregna-4,8(14)-dien-20-yn-3-one 18,19-Dinorpregna-4,8(14)-dien-20-yn-3-one, 13-ethyl-17-hydroxy-, (17α)-(±); (17α)-(±)-13-Ethyl-17-hydroxy-18,19-dinorpregna-4,8(14)-dien-20-yn-3-one; 8(14)-Dehydronorgestrel;
Levonorgestrel EP Impurity A is a fully characterized chemical compound used as a reference standard of API Levonorgestrel. The standard offered is compliant with regulatory guidelines. Levonorgestrel EP Impurity A is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 110785-09-6
Related products
(S)-2-Amino-3-(3,5-diiodo-4-(4-methoxyphenoxy)phenyl Propanoic Acid

M.F.
M.W. 539.11
CAT# AR-L13658
CAS# 94345-95-6